RECURRENT NASOPHARYNX CARCINOMA
Clinical trials for RECURRENT NASOPHARYNX CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT NASOPHARYNX CARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT NASOPHARYNX CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New triple therapy aims to control advanced nose cancer
Disease control Recruiting nowThis study tests a combination of three drugs—an EGFR antibody, a PD-1 inhibitor, and chemotherapy—in people whose nasopharyngeal cancer has returned or spread. The goal is to see if this mix can slow or stop the cancer from growing. About 148 adults aged 18-75 who have not had p…
Matched conditions: RECURRENT NASOPHARYNX CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Second radiation may boost survival in returning throat cancer
Disease control Recruiting nowThis study is for people whose nasopharyngeal cancer has come back after initial treatment and cannot be removed by surgery. Participants first receive a combination of chemotherapy and an immunotherapy drug (PD-1 inhibitor). Those whose tumors shrink or disappear are then random…
Matched conditions: RECURRENT NASOPHARYNX CARCINOMA
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC